Literature DB >> 1634814

Degree and length of viremia in adults with measles.

D N Forthal1, S Aarnaes, J Blanding, L de la Maza, J G Tilles.   

Abstract

Measles viremia is thought to peak at onset of rash and diminish rapidly over the subsequent 2-3 days. The length of viremia and the proportion of peripheral blood mononuclear cells (PBMC) infected during measles were investigated in 8 adults. Blood was obtained from 7 patients between days 2 and 4 of rash. Five patients had repeat specimens obtained on day 6 or 7, and 1 patient had samples taken on days 6 and 10. Limiting dilutions of PBMC were cultivated with cord blood PBMC and stimulated with phytohemagglutinin. Virus was identified by syncytia formation and confirmed by immunofluorescent staining. Virus was isolated from all 8 patients. Four of 6 patients were still viremic at day 6 or 7 of rash. Titers ranged from 3 to 5623 TCID50/10(5) PBMC. Adults with measles may have prolonged viremia, and a large proportion of PBMC may be infected.

Entities:  

Mesh:

Year:  1992        PMID: 1634814     DOI: 10.1093/infdis/166.2.421

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

Review 1.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

2.  Modulation of immune system function by measles virus infection: role of soluble factor and direct infection.

Authors:  R S Fujinami; X Sun; J M Howell; J C Jenkin; J B Burns
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

3.  Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus.

Authors:  Veronika von Messling; Nicholas Svitek; Roberto Cattaneo
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Roles of macrophages in measles virus infection of genetically modified mice.

Authors:  B Roscic-Mrkic; R A Schwendener; B Odermatt; A Zuniga; J Pavlovic; M A Billeter; R Cattaneo
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice.

Authors:  B Mrkic; B Odermatt; M A Klein; M A Billeter; J Pavlovic; R Cattaneo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA.

Authors:  P V Baskar; G D Collins; B A Dorsey-Cooper; R S Pyle; J E Nagel; D Dwyer; G Dunston; C E Johnson; N Kendig; E Israel; D R Nalin; W H Adler
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

7.  Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production.

Authors:  D Naniche; A Yeh; D Eto; M Manchester; R M Friedman; M B Oldstone
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Comparison of different methods and cell lines for isolating measles virus.

Authors:  D N Forthal; J Blanding; S Aarnaes; E M Peterson; L M de la Maza; J G Tilles
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

9.  Cell cycle arrest during measles virus infection: a G0-like block leads to suppression of retinoblastoma protein expression.

Authors:  D Naniche; S I Reed; M B Oldstone
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system.

Authors:  Veronika von Messling; Dragana Milosevic; Roberto Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.